Join our community of smart investors

Rentokil North America boss offloads £1.2m in shares

Rentokil Initial set to outline how it can benefit from greater interest in hygiene post-pandemic
Rentokil North America boss offloads £1.2m in shares
  • Rentokil Initial North America boss sells £1.2m in shares, his second major sale since August 2020
  • Hygiene and pest control company set for earnings growth even as Covid-19 hygiene rush drops off

Plague has joined pandemic as another catastrophe for 2021, although thankfully for the world this was just mice infestation in Australia rather than the Black Death 2.0. The rodent plague did, however, leave pest control and hygiene group Rentokil Initial (RTO) looking like Nostradamus, given an Australian business was part of its large run of acquisitions in 2020. 

The company surfed a Covid-19 wave over the past year, increasing adjusted earnings by 8 per cent as infection control spending overcame a slowdown in office demand. The hygiene and pest control company was trading at record highs at the end of 2020, getting close to 600p, but has since dropped back to around 500p. 

Overall, the pest control division is the company’s largest and most important. But it is hoping to hold on to the disinfectant growth seen last year. Management has announced a capital markets day for September with the title ‘Hygiene: the Next Pest Control?', so has given itself plenty of time to work this out. 

The outlook for this year is for operating profits from hygiene to dip from £173m in 2020 to £145m, according to consensus estimates compiled by FactSet, while sales for the division are forecast to climb 1 per cent. 

Rentokil North America managing director John Myers picked this environment to sell 250,000 shares in the company, for £1.2m. This is his second major share sale in 12 months. Myers sold 225,000 shares in August 2020, also reaping £1.2m from the earlier transaction. 

The company did not respond to a request for comment. 

Rentokil has solid earnings prospects even as the world happily looks to be on a less Covid-19-affected path. Buy at 492p. 

Last IC View: Buy, 473p, 4 Mar 2021

Buys    
CompanyDirector/PDMRDatePrice (p)Aggregate value (£)
British American TobaccoTadeu Marroco22 Mar 20212,830299,980
Cenkos SecuritiesLisa Gordon (ch)22 Mar 20217373,000
CentaminJames Rutherford (ch)23 Mar 202110451,925
CentaminMark Bankes23 Mar 202110531,395
CentaminProfessor Ibrahim Fawzy25 Mar 2021105146,790
ElementisAndrew Duff (ch)23 Mar 202111823,640
ElementisJohn O'Higgins23 Mar 202112072,192
FintelImogen Joss23 Mar 202120674,160
FintelNeil Stevens (j-ce)23 Mar 202121249,996
FintelMatt Timmins (j-ce)23 Mar 202121231,800
Kenmare ResourcesSteven McTiernan26 Mar 20214849,996
Sabre InsuranceGeoff Carter (ce)25 Mar 202124149,502
SSPJudy Vezmar23 Mar 202133754,152
SSPRichard Lewis23 Mar 202133326,635
Sells    
CompanyDirector/PDMRDatePrice (p)Aggregate value (£)
AvastWarren Finegold22 Mar 2021478325,671
BangoGianluca D'Agostino24 Mar 202120740,385
Brooks MacdonaldAndrew Shepherd25 Mar 20212,180109,000
GreggsRoger Whiteside (ce)23 Mar 20212,0882,144,139
HSBCGeorges Elhedery (PDMR)22 Mar 2021426284,159
Nexus InfrastructureJohn Hillman (cs)26 Mar 2021167125,250
RenewiBas van Ginkel22 Mar 20214855,008
Rentokil InitialJohn Myers24 Mar 20214911,226,875
Standard CharteredJudy Hsu24 Mar 2021488465,154
Watches of SwitzerlandBrian Duffy (ce)22 Mar 20216636,632,500
Wizz AirWilliam A. Franke (ch)18 Mar 20215,200400,000,016